America's #patent system is technology-neutral, so policies apply equally across industries.

The #ETHICAct would mark a historic departure from that neutrality.

Learn more about why we oppose the bill ⬇️

If enacted, the #ETHICAct would deny #innovators the ability to protect the full scope of their #inventions. That is a major break from basic principles of #intellectualproperty law.

For more facts, check out our issue brief on the bill:

Read our new letter to the House Judiciary #IP Subcommittee correcting several misleading claims that underpin the #ETHICAct:

"Any discussion of the ETHIC Act should proceed from an accurate understanding of continuation practice, obviousness-type double #patenting, and terminal disclaimers..."

The #ETHICAct would upend patent prosecution practices that have evolved to make the process manageable.

Additionally, the bill would actively disincentivize #innovation, resulting in fewer advances that benefit patients and ultimately become available in generic forms.

Learn more: